Demonstration of the Maintaining of the Validated State of a System Used to Generate Water for Injection by Thermocompression Distillation

References

1. 1.↵
   1. Gsell G.,
   2. V. Nunez C.,
   3. Smith-Palmer M.

   Advances in Vapor Compression Technology for the Production of USP Purified Water and Water for Injection. Pharmaceutical Engineering 2013, 33 (2) 1–8.

   OpenUrlGoogle Scholar
2. 2.↵
   U.S. Food and Drug Administration. Process Validation: General Principles and Practices, 2011, January.

   Google Scholar
3. 3.↵
   EudraLex. Good Manufacturing Practice (GMP) Guidelines, Annex 15 Qualification and Validation, 2015, Vol. 4, March.

   Google Scholar
4. 4.↵
   WHO Technical Report Series, No. 970, 2012. Annex 2 WHO Good Manufacturing Practices: Water for Pharmaceutical Use.

   Google Scholar
5. 5.↵
   United States Pharmacopoeia 36—National Formulary 31; United States Pharmacopoeial Convention: Rockville, MD, 2013.

   Google Scholar
6. 6.↵
   Water for Injection. In European Pharmacopoeia 5.0; European Pharmacopoeia Commission: Strasbourg, France, 2005; pp 2692–2694.

   Google Scholar
7. 7.↵
   WHO Technical Report No. 929, 2005. Annex 3 WHO Good Manufacturing Practices: Water for Pharmaceutical Use.

   Google Scholar
8. 8.↵
   Mantenimiento preventivo planificado asistido por computadora SGestMan. Website: www.gamma.com.cu/es/node/66.

   Google Scholar
9. 9.↵
   General Chapter <645> Water Conductivity. In United States Pharmacopoeia 37—National Formulary 32; United States Pharmacopoeial Convention: Rockville, MD, 2014.

   Google Scholar
10. 10.↵
    1. Barron J. J.,
    2. Ashton C.

    The Effect of Temperature on Conductivity Measurement. TSP 2005, 7 (73), 1–5.

    OpenUrlGoogle Scholar
11. 11.↵
    General Chapter <643> Total Organic Carbon. In United States Pharmacopoeia 37—National Formulary 32; United States Pharmacopoeial Convention: Rockville, MD, 2014.

    Google Scholar
12. 12.↵
    2.2.44. TOC in Water for Pharmaceutical Use. In European Pharmacopoeia 5.0; European Pharmacopoeia Commission: Strasbourg, France, 2005.

    Google Scholar
13. 13.↵
    1. Matsuda R.,
    2. Ishihach M.,
    3. Uchiyama M.,
    4. Hiraoka T,
    5. Hoshida H,
    6. Kunihiro Y,
    7. Miki H,
    8. Nishimoto Y,
    9. Inazu K,
    10. Mizuno T,
    11. et al

    . Total Organic Carbon as an Index for Specification of Water for Injection. J. Assoc. Off. Anal. Chem. 1987, 70 (4), 681–686.

    OpenUrlPubMedGoogle Scholar
14. 14.↵
    ISPE Good Practice Guide: Approaches to Commissioning and Qualification of Pharmaceutical Water and Steam Systems (Second Edition), 2014.

    Google Scholar
15. 15.↵
    1. Jahnke M.

    Microbiological Leak Test of Supply Pipes for Pharmaceutical Process Water. European J. Parenteral Sci. 2000, 5 (3), 75–78.

    OpenUrlGoogle Scholar
16. 16.↵
    General Chapter <85> Bacterial Endotoxins Test In In United States Pharmacopoeia 37—National Formulary 32; United States Pharmacopoeial Convention: Rockville, MD, 2014.

    Google Scholar
17. 17.↵
    1. Martínez J. E

    . Hyperthermophilic Microorganisms and USP Hot Water Systems. Pharm. Technol. 2004, 28 (2), 50–65.

    OpenUrlGoogle Scholar
18. 18.↵
    1. Vincent D. W.

    Qualification of Purified Water Systems. J. Validation Technol. 2013, 10 (1), 50–61.

    OpenUrlGoogle Scholar